Watch those drug holidays for fracture risk

Experts urge caution with temporarily ceasing bisphosphonate therapy
holiday

Drug holidays for patients with osteoporosis are riskier than previously thought and need further assessment, a team of US endocrinologists argue.

Temporarily ceasing bisphosphonate therapy is often recommended to lower the risk of rare adverse events, such as medication-related osteonecrosis of the jaw and atypical femur fracture.